The 33rd Annual Mayo Clinic Hematology/Oncology Reviews 2024 is a course dedicated to the clinical application of new research developments over the preceding year in the fields of oncology and hematology including new therapy options and management of various types of cancer such as gastroesophageal cancer, pancreaticobiliary cancers, colorectal cancer, soft tissue and bone sarcomas and prostate cancer.
The 33rd Annual Mayo Clinic Hematology/Oncology Reviews 2024 brings together hematologists, oncologists and other health professionals interested in Hematology and Oncology updates.